GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
0.7011
-0.0236 (-3.26%)
Aug 4, 2026, 9:14 AM EDT - Market open
GeoVax Labs Market Cap
GeoVax Labs has a market cap or net worth of $5.17 million as of August 4, 2026. Its market cap has decreased by -71.89% in one year.
Market Cap
5.17M
Enterprise Value
2.52M
1-Year Change
-71.89%
Ranking
Category
Stock Price
$0.70
ChartMarket Cap Chart
Since September 11, 2019, GeoVax Labs's market cap has increased from $239.88K to $5.17M, an increase of 2,053.82%. That is a compound annual growth rate of 56.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 5.17M | -29.65% |
| Dec 31, 2025 | 7.34M | -68.49% |
| Dec 31, 2024 | 23.31M | 141.85% |
| Dec 29, 2023 | 9.64M | -41.93% |
| Dec 30, 2022 | 16.60M | -28.16% |
| Dec 31, 2021 | 23.10M | 92.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NuCana | 5.49M |
| BioAtla | 5.46M |
| Evogene | 5.28M |
| BioRestorative Therapies | 5.22M |
| CollPlant Biotechnologies | 5.16M |
| Aptevo Therapeutics | 5.12M |
| Bio Green Med Solution | 4.91M |
| Dermata Therapeutics | 4.71M |